Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 237

    1.

    Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.

    Karp JE, Merz WG, Hendricksen C, Laughon B, Redden T, Bamberger BJ, Bartlett JG, Saral R, Burke PJ.

    Ann Intern Med. 1987 Jan;106(1):1-7.PMID: 3538962 [PubMed - indexed for MEDLINE]Related articles

    2.

    Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract.

    Karp JE, Merz WG, Hendricksen C, Laughon B, Redden T, Bamberger BJ, Bartlett JG, Saral R, Burke PJ.

    Scand J Infect Dis Suppl. 1986;48:66-78.PMID: 3535055 [PubMed - indexed for MEDLINE]Related articles

    3.

    Systemic infection and colonization with and without prophylactic norfloxacin use over time in the granulocytopenic, acute leukemia patient.

    Karp JE, Dick JD, Merz WG.

    Eur J Cancer Clin Oncol. 1988;24 Suppl 1:S5-13.PMID: 3127219 [PubMed - indexed for MEDLINE]Related articles

    4.

    Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia.

    Karp JE, Dick JD, Angelopulos C, Charache P, Green L, Burke PJ, Saral R.

    Am J Med. 1986 Aug;81(2):237-42.PMID: 3526884 [PubMed - indexed for MEDLINE]Related articles

    5.

    Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group.

    Talbot GH, Cassileth PA, Paradiso L, Correa-Coronas R, Bond L.

    Antimicrob Agents Chemother. 1993 Mar;37(3):474-82.PMID: 8460916 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant patients.

    Zwaveling JH, Maring JK, Klompmaker IJ, Haagsma EB, Bottema JT, Laseur M, Winter HL, van Enckevort PJ, TenVergert EM, Metselaar HJ, Bruining HA, Slooff MJ.

    Crit Care Med. 2002 Jun;30(6):1204-9.PMID: 12072669 [PubMed - indexed for MEDLINE]Related articles

    7.

    Norfloxacin for prevention of bacterial infections in granulocytopenic patients.

    Winston DJ, Ho WG, Champlin RE, Karp J, Bartlett J, Finley RS, Joshi JH, Talbot G, Levitt L, Deresinski S, et al.

    Am J Med. 1987 Jun 26;82(6B):40-6.PMID: 3037899 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.

    Bow EJ, Rayner E, Louie TJ.

    Am J Med. 1988 May;84(5):847-54.PMID: 3284340 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prophylactic administration of oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemias.

    Liso V, Specchia G, Pavone V, Pansini N, Capalbo S, Ostuni A, Mastria A, Colucci A, Costantino G.

    J Chemother. 1989 Jul;1(4 Suppl):1297-9. No abstract available. PMID: 16312873 [PubMed - indexed for MEDLINE]Related articles

    12.

    Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients.

    Winston DJ, Ho WG, Nakao SL, Gale RP, Champlin RE.

    Am J Med. 1986 May;80(5):884-90.PMID: 3010716 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prevention of gram-negative bacterial infection in granulocytopenic patients: a randomized study comparing oral norfloxacin with gentamycin.

    Nemet D, Kalenic S, Badanjak A, Bogdanic V, Davila N, Francetić I, Labar B.

    Bone Marrow Transplant. 1989 Dec;4 Suppl 3:105. No abstract available. PMID: 2697389 [PubMed - indexed for MEDLINE]Related articles

    15.

    Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia.

    Maschmeyer G, Haralambie E, Gaus W, Kern W, Dekker AW, De Vries-Hospers HG, Sizoo W, König W, Gutzler F, Daenen S.

    Infection. 1988 Mar-Apr;16(2):98-104.PMID: 3286509 [PubMed - indexed for MEDLINE]Related articles

    16.

    Norfloxacin versus cotrimoxazole for infection prophylaxis in granulocytopenic patients with acute leukemia. A prospective randomized study.

    Orlandi E, Navarra A, Cruciani M, Caldera D, Morra E, Castagnola C, Concia E, Bernasconi C.

    Haematologica. 1990 May-Jun;75(3):296-8.PMID: 2227631 [PubMed - indexed for MEDLINE]Related articles

    17.

    Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study.

    Guiot HF, van den Broek PJ, van der Meer JW, van Furth R.

    J Infect Dis. 1983 Apr;147(4):615-23.PMID: 6842002 [PubMed - indexed for MEDLINE]Related articles

    18.

    Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia.

    Kern W, Kurrle E.

    Infection. 1991 Mar-Apr;19(2):73-80.PMID: 2050424 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole.

    Wingard JR, Vaughan WP, Braine HG, Merz WG, Saral R.

    Am J Med. 1987 Dec;83(6):1103-10.PMID: 3332568 [PubMed - indexed for MEDLINE]Related articles

    20.

    Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group.

    Wiström J, Jertborn M, Ekwall E, Norlin K, Söderquist B, Strömberg A, Lundholm R, Hogevik H, Lagergren L, Englund G, et al.

    Ann Intern Med. 1992 Aug 1;117(3):202-8.PMID: 1616214 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data